Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.

Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, Miller MD, Lu B, Cheng AK; 903 Study Team.; 907 Study Team..

J Infect Dis. 2004 Apr 1;189(7):1185-92. Epub 2004 Mar 12.

PMID:
15031786
2.

Tenofovir disoproxil fumarate.

Chapman T, McGavin J, Noble S.

Drugs. 2003;63(15):1597-608. Review.

PMID:
12887265
3.

Tenofovir for the treatment of hepatitis B virus.

Jenh AM, Thio CL, Pham PA.

Pharmacotherapy. 2009 Oct;29(10):1212-27. doi: 10.1592/phco.29.10.1212. Review.

PMID:
19792994
4.

Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.

Antoniou T, Park-Wyllie LY, Tseng AL.

Pharmacotherapy. 2003 Jan;23(1):29-43. Review.

PMID:
12523458
5.

Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.

Fung HB, Stone EA, Piacenti FJ.

Clin Ther. 2002 Oct;24(10):1515-48. Review.

PMID:
12462284
6.

Emtricitabine/tenofovir disoproxil fumarate.

[No authors listed]

Drugs R D. 2004;5(3):160-1. Review.

PMID:
15139777
7.

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.

Jenh AM, Pham PA.

Expert Rev Anti Infect Ther. 2010 Oct;8(10):1079-92. doi: 10.1586/eri.10.91. Review.

PMID:
20954872
8.

[Treatment of chronic hepatitis B in HIV co-infected patients].

Massard J, Benhamou Y.

Gastroenterol Clin Biol. 2008 Jan;32(1 Pt 2):S20-4. doi: 10.1016/S0399-8320(08)73261-5. Review. French.

9.

Hepatitis B virus and HIV infection.

Martín-Carbonero L, Poveda E.

Semin Liver Dis. 2012 May;32(2):114-9. doi: 10.1055/s-0032-1316466. Epub 2012 Jul 3. Review.

PMID:
22760650
10.

Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.

Fung J, Lai CL, Yuen MF.

Expert Rev Anti Infect Ther. 2010 Jun;8(6):717-26. doi: 10.1586/eri.10.45. Review.

PMID:
20521898
11.

Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.

Levy V, Grant RM.

Clin Infect Dis. 2006 Oct 1;43(7):904-10. Epub 2006 Aug 23. Review. Erratum in: Clin Infect Dis. 2006 Nov 15;43(10):1376.

PMID:
16941375
12.

Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.

Soriano V, de Mendoza C, Peña JM, Barreiro P.

Expert Opin Pharmacother. 2015 Feb;16(2):179-86. doi: 10.1517/14656566.2015.973852. Epub 2014 Dec 22. Review.

PMID:
25529507
13.

HIV and hepatitis B virus: options for managing coinfection.

Dieterich DT.

Top HIV Med. 2003 Jan-Feb;11(1):16-9. Review.

14.

Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, Patroni A, Castelli F, Sacchi P, Filice G, Carosi G.

AIDS Rev. 2002 Jan-Mar;4(1):27-35. Review.

PMID:
11998781
15.

Hepatitis B in HIV-infected patients.

Soriano V, Poveda E, Vispo E, Barreiro P.

Clin Liver Dis. 2013 Aug;17(3):489-501. doi: 10.1016/j.cld.2013.05.008. Epub 2013 Jul 8. Review.

PMID:
23905818
16.

A personalized approach to optimize hepatitis B treatment in treatment-naive patients.

Marcellin P, Liang J.

Antivir Ther. 2010;15 Suppl 3:53-9. doi: 10.3851/IMP1624. Review.

PMID:
21041904
17.

[Forecasting of efficacy of chronic hepatitis B therapy].

Dybowska D, Kozielewicz D, Halota W.

Przegl Epidemiol. 2012;66(1):45-8. Review. Polish.

18.

Tenofovir disoproxil fumarate: in chronic hepatitis B.

Perry CM, Simpson D.

Drugs. 2009 Nov 12;69(16):2245-56. doi: 10.2165/10482940-000000000-00000. Review.

PMID:
19852527
19.
20.

Management of chronic hepatitis B in the HIV-infected patient.

Thio CL.

AIDS Read. 2004 Mar;14(3):122-9, 133, 136-7. Review.

PMID:
15068000

Supplemental Content

Support Center